Skip to main content
Premium Trial:

Request an Annual Quote

Strand Life Sciences Completes $13M Financing Round

NEW YORK (GenomeWeb) – India's Strand Life Sciences today announced it closed a financing round that raised $13 million.

Private equity firm Quadria Capital led the investment. HealthQuad Fund and Heritas Venture Fund also participated.

The financing will be used to help Strand's growth initiatives, and the support of Quadria "will help launch Strand into its next phase of growth and into an era where data analytics and molecular measurements together change diagnosis and treatment paradigms," Strand CEO Ramesh Hariharan said in a statement.

Strand offers diagnostic tests, including genetic tests in the areas of cancer, women's health, wellness, fertility, and infectious diseases, according to its website. It also offers bioinformatics services and clinical research and development services to pharma and biotech firms.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.